GOSERELIN for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 136 adverse event reports in the FDA FAERS database where GOSERELIN was used for Neoplasm malignant.
Most Reported Side Effects for GOSERELIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 1,293 | 20.3% | 1,293 | 99 |
| Malignant neoplasm progression | 935 | 14.7% | 85 | 114 |
| Metastases to bone | 397 | 6.2% | 34 | 69 |
| Neutropenia | 339 | 5.3% | 16 | 45 |
| Fatigue | 309 | 4.9% | 27 | 76 |
| Off label use | 272 | 4.3% | 22 | 68 |
| Metastases to liver | 264 | 4.1% | 15 | 26 |
| Hot flush | 263 | 4.1% | 23 | 47 |
| Asthenia | 213 | 3.3% | 34 | 64 |
| Arthralgia | 190 | 3.0% | 9 | 57 |
| Drug ineffective | 189 | 3.0% | 21 | 55 |
| Disease progression | 181 | 2.8% | 24 | 14 |
| Nausea | 177 | 2.8% | 7 | 43 |
| Pain | 167 | 2.6% | 16 | 50 |
| Breast cancer | 151 | 2.4% | 10 | 10 |
Other Indications for GOSERELIN
Prostate cancer (2,080)
Product used for unknown indication (1,345)
Breast cancer (707)
Breast cancer metastatic (396)
Breast cancer female (190)
Prostate cancer metastatic (136)
Her2 positive breast cancer (99)
Invasive ductal breast carcinoma (78)
Endometriosis (76)
Her2 negative breast cancer (67)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)